RTN/Nogo 在形成阿尔茨海默病神经纤维缠结中的作用。
RTN/Nogo in forming Alzheimer's neuritic plaques.
机构信息
Department of Neurosciences, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
出版信息
Neurosci Biobehav Rev. 2010 Jul;34(8):1201-6. doi: 10.1016/j.neubiorev.2010.01.017. Epub 2010 Feb 6.
Abstract
One of the pathological hallmarks in brains of patients with Alzheimer's disease (AD) is the presence of neuritic plaques, in which amyloid deposits are surrounded by reactive gliosis and dystrophic neurites. Within neuritic plaques, reticulon 3 (RTN3), a homolog of Nogo protein, appears to regulate the formation of both amyloid deposition via negative modulation of BACE1 activity and dystrophic neurites via the formation of RTN3 aggregates. Transgenic mice over-expressing RTN3, but not the other known markers of dystrophic neurites in AD brain, spontaneously develop RTN3-immunoreactive dystrophic neurites. The presence of dystrophic neurites impairs cognition. Blocking abnormal RTN3 aggregation will increase the available RTN3 monomer and is therefore a promising therapeutic strategy for enhancing cognitive function in AD patients.
摘要
阿尔茨海默病（AD）患者大脑中的病理特征之一是存在神经纤维缠结，其中淀粉样沉积物被反应性神经胶质增生和退行性神经突所包围。在神经纤维缠结中，Reticulon 3（RTN3）是神经生长抑制因子蛋白的同源物，似乎通过负向调节 BACE1 活性来调节淀粉样沉积的形成，通过 RTN3 聚集来调节退行性神经突的形成。过表达 RTN3 的转基因小鼠会自发地产生 RTN3 免疫反应性退行性神经突，但不会产生 AD 脑中其他已知的退行性神经突标志物。退行性神经突的存在会损害认知。阻断异常 RTN3 聚集将增加可用的 RTN3 单体，因此是提高 AD 患者认知功能的有前途的治疗策略。
相似文献
1
RTN/Nogo in forming Alzheimer's neuritic plaques.
Neurosci Biobehav Rev. 2010 Jul;34(8):1201-6. doi: 10.1016/j.neubiorev.2010.01.017. Epub 2010 Feb 6.
2
Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities.
EMBO J. 2007 Jun 6;26(11):2755-67. doi: 10.1038/sj.emboj.7601707. Epub 2007 May 3.
3
BAP31 deficiency contributes to the formation of amyloid-β plaques in Alzheimer's disease by reducing the stability of RTN3.
FASEB J. 2019 Apr;33(4):4936-4946. doi: 10.1096/fj.201801702R. Epub 2018 Dec 31.
4
Accumulation of neutral lipids in dystrophic neurites surrounding amyloid plaques in Alzheimer's disease.
Biochim Biophys Acta Mol Basis Dis. 2024 Apr;1870(4):167086. doi: 10.1016/j.bbadis.2024.167086. Epub 2024 Feb 18.
5
Dynactin 6 deficiency enhances aging-associated dystrophic neurite formation in mouse brains.
Neurobiol Aging. 2021 Nov;107:21-29. doi: 10.1016/j.neurobiolaging.2021.07.006. Epub 2021 Jul 15.
6
RTN1 and RTN3 protein are differentially associated with senile plaques in Alzheimer's brains.
Sci Rep. 2017 Jul 21;7(1):6145. doi: 10.1038/s41598-017-05504-9.
7
Reduced amyloid deposition in mice overexpressing RTN3 is adversely affected by preformed dystrophic neurites.
J Neurosci. 2009 Jul 22;29(29):9163-73. doi: 10.1523/JNEUROSCI.5741-08.2009.
8
Mapping of interaction domains mediating binding between BACE1 and RTN/Nogo proteins.
J Mol Biol. 2006 Oct 27;363(3):625-34. doi: 10.1016/j.jmb.2006.07.094. Epub 2006 Aug 11.
9
Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice.
Neuroscience. 2010 Aug 11;169(1):488-94. doi: 10.1016/j.neuroscience.2010.04.045. Epub 2010 Apr 28.
10
Impact of RTN3 deficiency on expression of BACE1 and amyloid deposition.
J Neurosci. 2014 Oct 15;34(42):13954-62. doi: 10.1523/JNEUROSCI.1588-14.2014.
引用本文的文献
1
Circ_0043947 contributes to interleukin 1β-induced injury in chondrocytes by sponging miR-671-5p to up-regulate RTN3 expression in osteoarthritis pathology.
J Orthop Surg Res. 2022 Mar 24;17(1):177. doi: 10.1186/s13018-022-02970-4.
2
Dynactin 6 deficiency enhances aging-associated dystrophic neurite formation in mouse brains.
Neurobiol Aging. 2021 Nov;107:21-29. doi: 10.1016/j.neurobiolaging.2021.07.006. Epub 2021 Jul 15.
3
Activity of Alzheimer's γ-secretase is linked to changes of interferon-induced transmembrane proteins (IFITM) in innate immunity.
Mol Neurodegener. 2020 Nov 12;15(1):69. doi: 10.1186/s13024-020-00417-0.
4
Increased Reticulon 3 (RTN3) Leads to Obesity and Hypertriglyceridemia by Interacting With Heat Shock Protein Family A (Hsp70) Member 5 (HSPA5).
Circulation. 2018 Oct 23;138(17):1828-1838. doi: 10.1161/CIRCULATIONAHA.117.030718.
5
Identification of rare RTN3 variants in Alzheimer's disease in Han Chinese.
Hum Genet. 2018 Feb;137(2):141-150. doi: 10.1007/s00439-018-1868-1. Epub 2018 Jan 22.
6
RTN1 and RTN3 protein are differentially associated with senile plaques in Alzheimer's brains.
Sci Rep. 2017 Jul 21;7(1):6145. doi: 10.1038/s41598-017-05504-9.
7
Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies.
J Neurochem. 2016 Oct;139 Suppl 2(Suppl 2):224-236. doi: 10.1111/jnc.13583. Epub 2016 May 4.
8
Defining the earliest pathological changes of Alzheimer's disease.
Curr Alzheimer Res. 2016;13(3):281-7. doi: 10.2174/1567205013666151218150322.
9
Dysfunctional tubular endoplasmic reticulum constitutes a pathological feature of Alzheimer's disease.
Mol Psychiatry. 2016 Sep;21(9):1263-71. doi: 10.1038/mp.2015.181. Epub 2015 Dec 1.
10
Function of Nogo-A/Nogo-A receptor in Alzheimer's disease.
CNS Neurosci Ther. 2015 Jun;21(6):479-85. doi: 10.1111/cns.12387. Epub 2015 Mar 2.
本文引用的文献
1
Functional characterization of the trans-membrane domain interactions of the Sec61 protein translocation complex beta-subunit.
BMC Cell Biol. 2009 Oct 26;10:76. doi: 10.1186/1471-2121-10-76.
2
The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential.
J Neurosci. 2009 Oct 14;29(41):12787-94. doi: 10.1523/JNEUROSCI.3657-09.2009.
3
Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies.
Nat Rev Drug Discov. 2009 Oct;8(10):783-93. doi: 10.1038/nrd2959.
4
Nogo-B receptor stabilizes Niemann-Pick type C2 protein and regulates intracellular cholesterol trafficking.
Cell Metab. 2009 Sep;10(3):208-18. doi: 10.1016/j.cmet.2009.07.003.
5
Reduced amyloid deposition in mice overexpressing RTN3 is adversely affected by preformed dystrophic neurites.
J Neurosci. 2009 Jul 22;29(29):9163-73. doi: 10.1523/JNEUROSCI.5741-08.2009.
6
Reassessment of corticospinal tract regeneration in Nogo-deficient mice.
J Neurosci. 2009 Jul 8;29(27):8649-54. doi: 10.1523/JNEUROSCI.1864-09.2009.
7
The two-hydrophobic domain tertiary structure of reticulon proteins is critical for modulation of beta-secretase BACE1.
J Neurosci Res. 2009 Oct;87(13):2963-72. doi: 10.1002/jnr.22112.
8
The occurrence of aging-dependent reticulon 3 immunoreactive dystrophic neurites decreases cognitive function.
J Neurosci. 2009 Apr 22;29(16):5108-15. doi: 10.1523/JNEUROSCI.5887-08.2009.
9
Critical issues for successful immunotherapy in Alzheimer's disease: development of biomarkers and methods for early detection and intervention.
CNS Neurol Disord Drug Targets. 2009 Apr;8(2):144-59. doi: 10.2174/187152709787847324.
10
Expression of reticulon 3 in Alzheimer's disease brain.
Neuropathol Appl Neurobiol. 2009 Apr;35(2):178-88. doi: 10.1111/j.1365-2990.2008.00974.x.
Zotero 插件